Literature DB >> 18541624

A new self-rating scale for detecting atypical or second-generation antipsychotic side effects.

L Waddell1, M Taylor.   

Abstract

We aimed to construct and assess a new self rating scale to detect the side effects of second generation antipsychotics. This scale was designed to allow a timely, sensitive and reliable method of gathering information on the number and severity of side effects an individual suffers from. The Glasgow Antipscyhotic Side-effect Scale (GASS) was developed after literature review, discussion with members of the mental health team and with service user feedback. Fifty indivudals taking second generation antipsychotics completed the GASS along with the Liverpool Univeristy Neuroleptic Side Effect Rating Scale, and one week later completed the GASS for a second time. Fifty comparison subjects also completed the GASS. The GASS was shown to have good discrimatory power and construct validity, along with good re-test reliablity, and is put forward as a short, helpful and valid clinical tool.

Mesh:

Substances:

Year:  2008        PMID: 18541624     DOI: 10.1177/0269881107087976

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  36 in total

1.  Paliperidone Long-Acting Injections in Huntington's Disease for Motor and Behavioural Disturbances.

Authors:  Nameer van Oosterom; Theo Theodoros
Journal:  Clin Drug Investig       Date:  2019-04       Impact factor: 2.859

2.  Psychotropic medicine beliefs, side effects and adherence in schizophrenia: a patient-caregiver dyad perspective.

Authors:  Irene A Kretchy; Bernard Appiah; Kofi Agyabeng; Emmanuel M Kwarteng; Enyonam Ganyaglo; Grace Owusu Aboagye
Journal:  Int J Clin Pharm       Date:  2021-04-09

Review 3.  Common Data Elements for National Institute of Mental Health-Funded Translational Early Psychosis Research.

Authors:  Dost Öngür; Cameron S Carter; Raquel E Gur; Diana Perkins; Akira Sawa; Larry J Seidman; Carol Tamminga; Wayne Huggins; Carol Hamilton
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-06-29

4.  SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects.

Authors:  Peter M Haddad; W Wolfgang Fleischhacker; Joseph Peuskens; Roberto Cavallaro; Michael Ej Lean; Margarita Morozova; Gavin Reynolds; Jean-Michel Azorin; Pierre Thomas; Hans-Jürgen Möller
Journal:  Ther Adv Psychopharmacol       Date:  2014-02

5.  Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study.

Authors:  Solomon Moges; Tilahun Belete; Tesfa Mekonen; Melak Menberu
Journal:  Int J Ment Health Syst       Date:  2021-05-06

Review 6.  Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.

Authors:  Peter M Haddad; Cecilia Brain; Jan Scott
Journal:  Patient Relat Outcome Meas       Date:  2014-06-23

Review 7.  Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis.

Authors:  Ayala Shirazi; Brendon Stubbs; Lucia Gomez; Susan Moore; Fiona Gaughran; Robert J Flanagan; James H MacCabe; John Lally
Journal:  Int J Mol Sci       Date:  2016-06-02       Impact factor: 5.923

Review 8.  Eliciting adverse effects data from participants in clinical trials.

Authors:  Elizabeth N Allen; Clare Ir Chandler; Nyaradzo Mandimika; Cordelia Leisegang; Karen Barnes
Journal:  Cochrane Database Syst Rev       Date:  2018-01-16

9.  A cluster randomised controlled trial and process evaluation of a training programme for mental health professionals to enhance user involvement in care planning in service users with severe mental health issues (EQUIP): study protocol for a randomised controlled trial.

Authors:  Peter Bower; Chris Roberts; Neil O'Leary; Patrick Callaghan; Penny Bee; Claire Fraser; Chris Gibbons; Nicola Olleveant; Anne Rogers; Linda Davies; Richard Drake; Caroline Sanders; Oonagh Meade; Andrew Grundy; Lauren Walker; Lindsey Cree; Kathryn Berzins; Helen Brooks; Susan Beatty; Patrick Cahoon; Anita Rolfe; Karina Lovell
Journal:  Trials       Date:  2015-08-13       Impact factor: 2.279

10.  Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial.

Authors:  Dong Roman Xu; Wenjie Gong; Eric D Caine; Shuiyuan Xiao; James P Hughes; Marie Ng; Jane Simoni; Hua He; Kirk L Smith; Henry Shelton Brown; Stephen Gloyd
Journal:  BMJ Open       Date:  2016-01-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.